ReviewIbrain2026

Preclinical advances in antibodies against N-terminal Aβ4-x species for Alzheimer's disease and cerebral amyloid angiopathy.

Maria Luisa Valle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.